Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comorbid Depression and Diabetic Foot Ulcers.

Home healthcare now·2016

Same author

Co-morbid Depression and Cardiovascular Disease in the Older Adult Homecare Patient.

Home healthcare now·2015

Same author

Diabetes, depression, and OASIS-C: a guide for home healthcare clinicians.

Home healthcare nurse·2014

Same author

Type 2 diabetes and vascular dementia: assessment and clinical strategies of care.

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses·2013

Same author

The value of daily money management: an analysis of outcomes and costs.

Journal of evidence-based social work·2012

Same author

Racial and ethnic diversity in senior centers: comparing participant characteristics in more and less multicultural settings.

Journal of gerontological social work·2012

Search research articles

Related Experiment Video

Updated: May 26, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Can treating depression improve diabetic management?

Anna M Acee¹, Marianne C Fahs

¹Long Island University, School of Nursing, Brooklyn, NY, USA.

The Nurse Practitioner

|January 6, 2012

Summary

Diabetes and depression management is complex. Antidepressant use in diabetic patients correlated with higher Patient Health Questionnaire (PHQ)-9 depression scores and HbA1C levels, indicating potential challenges in glycemic control.

Related Experiment Videos

Last Updated: May 26, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Area of Science:

Internal Medicine
Endocrinology
Psychiatry

Background:

Comorbid depression in diabetes mellitus significantly elevates healthcare utilization, costs, and complication risks.
Effective management of diabetes with co-occurring depression is crucial for patient outcomes.

Purpose of the Study:

To investigate current clinical practice patterns for managing diabetes, specifically assessing glycemic control via HbA1C.
To examine the relationship between antidepressant medication use and key health indicators in diabetic patients.

Main Methods:

Retrospective analysis of patient data.
Measurement of glycated hemoglobin (HbA1C) levels to assess long-term glycemic control.
Utilized Patient Health Questionnaire (PHQ)-9 scores to evaluate depression severity.

Main Results:

A significant positive correlation was observed between the use of antidepressant medications and elevated HbA1C levels in patients with diabetes.
Patients on antidepressants showed statistically significant increases in their Patient Health Questionnaire (PHQ)-9 scores, indicating higher depression severity.

Conclusions:

Current treatment patterns may face challenges in optimizing glycemic control for diabetic patients with depression, particularly those on antidepressants.
Further research is warranted to explore interventions that improve both mental health and glycemic control in this patient population.